K-Bro Linen (TSE:KBL – Get Rating) had its target price lifted by equities research analysts at TD Securities from C$37.00 to C$39.00 in a research report issued to clients and investors on Wednesday, BayStreet.CA reports. The firm presently has a “buy” rating on the stock. TD Securities’ price objective indicates a potential upside of 24.52% from the company’s current price.
Other equities research analysts have also issued research reports about the company. Raymond James lowered K-Bro Linen from a “strong-buy” rating to an “outperform” rating and dropped their price target for the stock from C$47.00 to C$37.50 in a research note on Thursday, March 23rd. Cormark lifted their price target on K-Bro Linen from C$38.00 to C$42.00 in a research report on Wednesday. Finally, Acumen Capital reduced their price target on shares of K-Bro Linen from C$38.00 to C$36.00 in a research report on Thursday, March 23rd.
K-Bro Linen Stock Performance
Shares of K-Bro Linen stock opened at C$31.32 on Wednesday. The company has a current ratio of 1.86, a quick ratio of 0.87 and a debt-to-equity ratio of 55.98. The stock’s fifty day moving average price is C$29.10 and its 200-day moving average price is C$29.02. The firm has a market cap of C$337.32 million, a P/E ratio of 87.00, a P/E/G ratio of 3.50 and a beta of 1.18. K-Bro Linen has a 12 month low of C$26.53 and a 12 month high of C$33.50.
About K-Bro Linen
K-Bro Linen Inc, together with its subsidiaries, provides laundry and linen services to healthcare institutions, hotels, and other commercial organizations in Canada and the United Kingdom. Its services include processing, management, and distribution of general and operating room linens, such as sheets, blankets, towels, surgical gowns, and drapes and other linens.
Recommended Stories
- It’s Time To Take Another Bite Of Take-Two Interactive
- Zoetis Declares New Dividend, Hinting At Undervaluation
- Good News For Walmart Isn’t So Great For Everybody Else
- Eagle Materials, Answering America’s Building Supply Needs
- Pharma Giants Novartis, Lilly, Merck, and Novo Outperform Market
Receive News & Ratings for K-Bro Linen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K-Bro Linen and related companies with MarketBeat.com's FREE daily email newsletter.